4

MAIN DOCUMENT DESCRIPTION

Company: Vanda Pharmaceuticals Inc.
Filed: April 18, 2006
Period of Report: April 18, 2006
Accession Number: 0001209191-06-024447

View Document ↗ View on SEC.gov ↗